tegafur has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shakhbazova, A | 1 |
| Marsch, AF | 1 |
| Miyagawa, F | 1 |
| Sugano, Y | 1 |
| Sho, M | 1 |
| Asada, H | 1 |
1 review available for tegafur and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
Topics: Age Distribution; Aged; Antimetabolites, Antineoplastic; Capecitabine; Female; Fluorouracil; Humans; | 2019 |
1 other study available for tegafur and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Therapy, Combination; Fluo | 2017 |